{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:12:55Z","timestamp":1794013975100,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Haiyan Foundation of Harbin Medical University Cancer Hospital","award":["JJMS2021-12"],"award-info":[{"award-number":["JJMS2021-12"]}]},{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"publisher","award":["YXJL-2023-0733-0161"],"award-info":[{"award-number":["YXJL-2023-0733-0161"]}],"id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03728-w","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:14:03Z","timestamp":1780416843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism study of RUNX1\/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer"],"prefix":"10.1186","volume":"27","author":[{"given":"Changjun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"3728_CR1","doi-asserted-by":"publisher","first-page":"111450","DOI":"10.1016\/j.biopha.2021.111450","volume":"138","author":"S Xie","year":"2021","unstructured":"Xie S, Wu Z, Qi Y, Wu B, Zhu X. The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. Biomed Pharmacother. 2021;138:111450.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3728_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS. Lung Cancer. 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41(1):1\u201324.","journal-title":"Clin Chest Med"},{"key":"3728_CR3","doi-asserted-by":"crossref","unstructured":"Tang S, Qin C, Hu H, Liu T, He Y, Guo H et al. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects. Cells. 2022;11(3):320.","DOI":"10.3390\/cells11030320"},{"issue":"6","key":"3728_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1200\/JCO.21.01707","volume":"40","author":"KA Higgins","year":"2022","unstructured":"Higgins KA, Puri S, Gray JE. Systemic and Radiation Therapy Approaches for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2022;40(6):576\u201385.","journal-title":"J Clin Oncol"},{"key":"3728_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","volume":"40","author":"MD Vesely","year":"2022","unstructured":"Vesely MD, Zhang T, Chen L. Resistance Mechanisms to Anti-PD Cancer Immunotherapy. Annu Rev Immunol. 2022;40:45\u201374.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"3728_CR6","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1097\/JS9.0000000000001582","volume":"110","author":"L Li","year":"2024","unstructured":"Li L, Wang H, Zhang S, Gao S, Lu X, Pan Y, et al. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8\u2009+\u2009T cytotoxicity for better prognosis in breast cancer. Int J Surg. 2024;110(8):4716\u201326.","journal-title":"Int J Surg"},{"key":"3728_CR7","doi-asserted-by":"publisher","first-page":"104258","DOI":"10.1016\/j.phrs.2019.104258","volume":"145","author":"AL Shergold","year":"2019","unstructured":"Shergold AL, Millar R, Nibbs RJB. Understanding and overcoming the resistance of cancer to PD-1\/PD-L1 blockade. Pharmacol Res. 2019;145:104258.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3728_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M de la Rojo","year":"2018","unstructured":"de la Rojo M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018;34(1):21\u201343.","journal-title":"Cancer Cell"},{"key":"3728_CR9","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"3728_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/scitranslmed.aau1167","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yao Y, Zhang S, Liu Y, Guo H, Ahmed M, et al. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019;11:491.","journal-title":"Sci Transl Med"},{"issue":"614","key":"3728_CR11","doi-asserted-by":"publisher","first-page":"eabg6428","DOI":"10.1126\/scitranslmed.abg6428","volume":"13","author":"KR Zhang","year":"2021","unstructured":"Zhang KR, Zhang YF, Lei HM, Tang YB, Ma CS, Lv QM, et al. Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Sci Transl Med. 2021;13(614):eabg6428.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3728_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","volume":"23","author":"CL Chen","year":"2016","unstructured":"Chen CL, Uthaya Kumar DB, Punj V, Xu J, Sher L, Tahara SM, et al. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism. Cell Metab. 2016;23(1):206\u201319.","journal-title":"Cell Metab"},{"issue":"1","key":"3728_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, et al. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia. Cancer Cell. 2019;36(1):84\u2013e998.","journal-title":"Cancer Cell"},{"issue":"10","key":"3728_CR14","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","volume":"10","author":"N Aroua","year":"2020","unstructured":"Aroua N, Boet E, Ghisi M, Nicolau-Travers ML, Saland E, Gwilliam R, et al. Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia. Cancer Discov. 2020;10(10):1544\u201365.","journal-title":"Cancer Discov"},{"issue":"11","key":"3728_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"issue":"5","key":"3728_CR16","doi-asserted-by":"publisher","first-page":"e0155660","DOI":"10.1371\/journal.pone.0155660","volume":"11","author":"WC Chen","year":"2016","unstructured":"Chen WC, Wang CY, Hung YH, Weng TY, Yen MC, Lai MD. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer. PLoS ONE. 2016;11(5):e0155660.","journal-title":"PLoS ONE"},{"issue":"1","key":"3728_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"3728_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt SM. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363\u201393.","journal-title":"Dev Cell"},{"key":"3728_CR19","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.","DOI":"10.1084\/jem.20201606"},{"key":"3728_CR20","doi-asserted-by":"crossref","unstructured":"Eltayeb K, La Monica S, Tiseo M, Alfieri R, Fumarola C. Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer. Cells. 2022;11(3):413.","DOI":"10.3390\/cells11030413"},{"issue":"9","key":"3728_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/1541-7786.MCR-21-1069","volume":"20","author":"JS Scott","year":"2022","unstructured":"Scott JS, Nassar ZD, Swinnen JV, Butler LM. Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer. Mol Cancer Res. 2022;20(9):1354\u201364.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"3728_CR22","doi-asserted-by":"publisher","first-page":"158964","DOI":"10.1016\/j.bbalip.2021.158964","volume":"1866","author":"R Jin","year":"2021","unstructured":"Jin R, Hao J, Yi Y, Sauter E, Li B. Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(8):158964.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3728_CR23","doi-asserted-by":"publisher","first-page":"120621","DOI":"10.1016\/j.lfs.2022.120621","volume":"301","author":"KA Garcia","year":"2022","unstructured":"Garcia KA, Costa ML, Lacunza E, Martinez ME, Corsico B, Scaglia N. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma. Life Sci. 2022;301:120621.","journal-title":"Life Sci"},{"issue":"19","key":"3728_CR24","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.1111\/jcmm.16815","volume":"25","author":"J Chen","year":"2021","unstructured":"Chen J, Alduais Y, Zhang K, Zhu X, Chen B. CCAT1\/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K\/AKT\/mTOR signalling in lung adenocarcinoma. J Cell Mol Med. 2021;25(19):9199\u2013213.","journal-title":"J Cell Mol Med"},{"issue":"13","key":"3728_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/1873-3468.14106","volume":"595","author":"S Yang","year":"2021","unstructured":"Yang S, Kobayashi S, Sekino K, Kagawa Y, Miyazaki H, Kumar Shil S, et al. Fatty acid-binding protein 5 controls lung tumor metastasis by regulating the maturation of natural killer cells in the lung. FEBS Lett. 2021;595(13):1797\u2013805.","journal-title":"FEBS Lett"},{"issue":"5","key":"3728_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","volume":"6","author":"J Wang","year":"2024","unstructured":"Wang J, Yang Y, Shao F, Meng Y, Guo D, He J, et al. Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc. Nat Metab. 2024;6(5):914\u201332.","journal-title":"Nat Metab"},{"issue":"8","key":"3728_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/cac2.70038","volume":"45","author":"M Lao","year":"2025","unstructured":"Lao M, Zhang X, Li Z, Sun K, Yang H, Wang S, et al. Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Cancer Commun (Lond). 2025;45(8):1010\u201337.","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"3728_CR28","doi-asserted-by":"publisher","first-page":"e2414100","DOI":"10.1002\/advs.202414100","volume":"12","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Tian F, Fan W, Li X, Wang X, Zhang H, et al. Targeting piRNA-137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma. Adv Sci (Weinh). 2025;12(6):e2414100.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3728_CR29","doi-asserted-by":"publisher","first-page":"e1639","DOI":"10.1002\/wrna.1639","volume":"12","author":"YS Chen","year":"2021","unstructured":"Chen YS, Yang WL, Zhao YL, Yang YG. Dynamic transcriptomic m(5) C and its regulatory role in RNA processing. Wiley Interdiscip Rev RNA. 2021;12(4):e1639.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3728_CR30","doi-asserted-by":"publisher","first-page":"1207371","DOI":"10.3389\/fimmu.2023.1207371","volume":"14","author":"X Gu","year":"2023","unstructured":"Gu X, Ma X, Chen C, Guan J, Wang J, Wu S, et al. Vital roles of m(5)C RNA modification in cancer and immune cell biology. Front Immunol. 2023;14:1207371.","journal-title":"Front Immunol"},{"issue":"1","key":"3728_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.","journal-title":"Mol Cancer"},{"issue":"39","key":"3728_CR32","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40(39):5814\u201328.","journal-title":"Oncogene"},{"key":"3728_CR33","doi-asserted-by":"crossref","unstructured":"Chellamuthu A, Gray SG. The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer. Cells. 2020;9(8):1758.","DOI":"10.3390\/cells9081758"},{"issue":"2","key":"3728_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Wei R, Zhang S, Hu S, Liang X, Yang Z, et al. NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation. Cell Death Dis. 2023;14(2):125.","journal-title":"Cell Death Dis"},{"key":"3728_CR35","doi-asserted-by":"crossref","unstructured":"Zheng Y, Ma C, Ding S, Zhang F, Liu H, Xu Y. NSUN2 Promotes the Growth, Metastasis and Glutamine Metabolism of Non-Small Cell Lung Cancer. Am J Respir Cell Mol Biol. 2025.","DOI":"10.1165\/rcmb.2025-0274OC"},{"issue":"4","key":"3728_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00262-025-03986-5","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang Y, Cao L, Xu X, Li D, Deng Y, Li L, et al. NSUN2\/ALYREF axis-driven m(5)C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. Cancer Immunol Immunother. 2025;74(4):132.","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"3728_CR37","doi-asserted-by":"publisher","first-page":"e23195","DOI":"10.1096\/fj.202300687RR","volume":"37","author":"H Ma","year":"2023","unstructured":"Ma H, Jiang S, Yuan Y, Li J, Li Y, Lv Y, et al. RUNX1 promotes proliferation and migration in non-small cell lung cancer cell lines via the mTOR pathway. FASEB J. 2023;37(11):e23195.","journal-title":"FASEB J"},{"issue":"3","key":"3728_CR38","doi-asserted-by":"publisher","first-page":"188715","DOI":"10.1016\/j.bbcan.2022.188715","volume":"1877","author":"TC Lin","year":"2022","unstructured":"Lin TC. RUNX1 and cancer. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188715.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"3728_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40364-024-00573-1","volume":"12","author":"X Guo","year":"2024","unstructured":"Guo X, Zhang H, He C, Qin K, Lai Q, Fang Y, et al. RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages. Biomark Res. 2024;12(1):29.","journal-title":"Biomark Res"},{"issue":"3","key":"3728_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/oncolo\/oyac253","volume":"28","author":"F Barlesi","year":"2023","unstructured":"Barlesi F, Isambert N, Felip E, Cho BC, Lee DH, Peguero J, et al. Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors. Oncologist. 2023;28(3):258\u201367.","journal-title":"Oncologist"},{"issue":"4","key":"3728_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/ol.2025.14921","volume":"29","author":"JH Jung","year":"2025","unstructured":"Jung JH, Yang Y, Kim Y. Hypoxia\u2013induced SREBP1\u2013mediated lipogenesis and autophagy promote cell survival via fatty acid oxidation in breast cancer cells. Oncol Lett. 2025;29(4):175.","journal-title":"Oncol Lett"},{"issue":"6","key":"3728_CR42","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.jbc.2021.101341","volume":"297","author":"PK Morgan","year":"2021","unstructured":"Morgan PK, Huynh K, Pernes G, Miotto PM, Mellett NA, Giles C, et al. Macrophage polarization state affects lipid composition and the channeling of exogenous fatty acids into endogenous lipid pools. J Biol Chem. 2021;297(6):101341.","journal-title":"J Biol Chem"},{"key":"3728_CR43","doi-asserted-by":"crossref","unstructured":"Zhang S, Peng W, Wang H, Xiang X, Ye L, Wei X et al. C1q(+) tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion. J Immunother Cancer. 2023;11(8):e007441.","DOI":"10.1136\/jitc-2023-007441"},{"issue":"7","key":"3728_CR44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/emmm.201202318","volume":"5","author":"HS Cheng","year":"2013","unstructured":"Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore D, et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013;5(7):1017\u201334.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"3728_CR45","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.7150\/thno.71029","volume":"12","author":"W Jin","year":"2022","unstructured":"Jin W, Zhao J, Yang E, Wang Y, Wang Q, Wu Y, et al. Neuronal STAT3\/HIF-1alpha\/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics. 2022;12(7):3196\u2013216.","journal-title":"Theranostics"},{"key":"3728_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/scitranslmed.aaz6314","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Hartman CL, Li L, Albert CJ, Si F, Gao A, et al. Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci Transl Med. 2021;13:587.","journal-title":"Sci Transl Med"},{"key":"3728_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fendo.2017.00293","volume":"8","author":"C Blucher","year":"2017","unstructured":"Blucher C, Stadler SC. Obesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression. Front Endocrinol (Lausanne). 2017;8:293.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3728_CR48","doi-asserted-by":"publisher","first-page":"1384778","DOI":"10.3389\/fonc.2024.1384778","volume":"14","author":"L Cheng","year":"2024","unstructured":"Cheng L, Li Z, Zheng Q, Yao Q. Correlation study of serum lipid levels and lipid metabolism-related genes in cervical cancer. Front Oncol. 2024;14:1384778.","journal-title":"Front Oncol"},{"issue":"2","key":"3728_CR49","doi-asserted-by":"publisher","first-page":"114573","DOI":"10.1016\/j.yexcr.2025.114573","volume":"448","author":"B Guo","year":"2025","unstructured":"Guo B, Wang K, Wu J, Yu H, Geng C, Jin Y, et al. Runx1 activates the transformation of adipocytes into cancer-associated adipocytes by downregulating Plin1. Exp Cell Res. 2025;448(2):114573.","journal-title":"Exp Cell Res"},{"key":"3728_CR50","doi-asserted-by":"crossref","unstructured":"Xu YY, Cheng GB, Li XY, Zeng XX, Wu SY. A novel angiogenesis-related gene signature predicting prognosis in clear cell renal cell carcinoma. Sci Rep. 2025;16(1):788.","DOI":"10.1038\/s41598-025-30376-9"},{"issue":"15","key":"3728_CR51","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.7150\/thno.44868","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, et al. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics. 2020;10(15):6561\u201380.","journal-title":"Theranostics"},{"issue":"45","key":"3728_CR52","doi-asserted-by":"publisher","first-page":"e07864","DOI":"10.1002\/advs.202507864","volume":"12","author":"B Tang","year":"2025","unstructured":"Tang B, Zhang X, Sun Y, Luo J, Weng Q, Zhang C, et al. Tumor-Targeted FABP5\/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma. Adv Sci (Weinh). 2025;12(45):e07864.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"3728_CR53","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41417-022-00510-0","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu J, Sun B, Guo K, Yang Z, Zhao Y, Gao M, et al. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma. Cancer Gene Ther. 2022;29(12):1951\u201360.","journal-title":"Cancer Gene Ther"},{"key":"3728_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12935-019-0941-8","volume":"19","author":"K Ni","year":"2019","unstructured":"Ni K, Wang D, Xu H, Mei F, Wu C, Liu Z, et al. miR-21 promotes non-small cell lung cancer cells growth by regulating fatty acid metabolism. Cancer Cell Int. 2019;19:219.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"3728_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","volume":"82","author":"X Yang","year":"2025","unstructured":"Yang X, Deng B, Zhao W, Guo Y, Wan Y, Wu Z, et al. FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. J Hepatol. 2025;82(4):676\u201389.","journal-title":"J Hepatol"},{"issue":"8040","key":"3728_CR56","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41586-024-08071-y","volume":"635","author":"SM Hwang","year":"2024","unstructured":"Hwang SM, Awasthi D, Jeong J, Sandoval TA, Chae CS, Ramos Y, et al. Transgelin 2 guards T cell lipid metabolism and antitumour function. Nature. 2024;635(8040):1010\u20138.","journal-title":"Nature"},{"issue":"3","key":"3728_CR57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and Function of the PD-L1 Checkpoint. Immunity. 2018;48(3):434\u201352.","journal-title":"Immunity"},{"issue":"4","key":"3728_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","volume":"3","author":"H Yao","year":"2019","unstructured":"Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng. 2019;3(4):306\u201317.","journal-title":"Nat Biomed Eng"},{"key":"3728_CR59","doi-asserted-by":"publisher","first-page":"596553","DOI":"10.3389\/fimmu.2020.596553","volume":"11","author":"JF Gutierrez-Bautista","year":"2020","unstructured":"Gutierrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, Jimenez P, Garrido F, Anderson P, et al. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset. Front Immunol. 2020;11:596553.","journal-title":"Front Immunol"},{"key":"3728_CR60","doi-asserted-by":"publisher","first-page":"908697","DOI":"10.3389\/fimmu.2022.908697","volume":"13","author":"A Alrubayyi","year":"2022","unstructured":"Alrubayyi A, Moreno-Cubero E, Hameiri-Bowen D, Matthews R, Rowland-Jones S, Schurich A, et al. Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction. Front Immunol. 2022;13:908697.","journal-title":"Front Immunol"},{"issue":"3","key":"3728_CR61","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1002\/ctm2.1621","volume":"14","author":"S Zou","year":"2024","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14(3):e1621.","journal-title":"Clin Transl Med"},{"issue":"12","key":"3728_CR62","doi-asserted-by":"publisher","first-page":"e1011808","DOI":"10.1371\/journal.ppat.1011808","volume":"19","author":"J Feng","year":"2023","unstructured":"Feng J, Xu T, He M, Li J, Yao P, Ma C, et al. NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. PLoS Pathog. 2023;19(12):e1011808.","journal-title":"PLoS Pathog"},{"issue":"4","key":"3728_CR63","doi-asserted-by":"publisher","first-page":"106793","DOI":"10.1016\/j.jbc.2024.106793","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang Z, Zhang C, Zhang L, Chen H, Xiao N, et al. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer. J Biol Chem. 2024;300(4):106793.","journal-title":"J Biol Chem"},{"issue":"9","key":"3728_CR64","doi-asserted-by":"publisher","first-page":"e0292212","DOI":"10.1371\/journal.pone.0292212","volume":"18","author":"L Zheng","year":"2023","unstructured":"Zheng L, Li M, Wei J, Chen S, Xue C, Duan Y, et al. NOP2\/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity. PLoS ONE. 2023;18(9):e0292212.","journal-title":"PLoS ONE"},{"key":"3728_CR65","doi-asserted-by":"publisher","first-page":"104554","DOI":"10.1016\/j.oraloncology.2019.104554","volume":"101","author":"L Lu","year":"2020","unstructured":"Lu L, Gaffney SG, Cannataro VL, Townsend J. Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma. Oral Oncol. 2020;101:104554.","journal-title":"Oral Oncol"},{"issue":"10","key":"3728_CR66","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782\u2013e988.","journal-title":"Cell Metab"},{"issue":"19","key":"3728_CR67","doi-asserted-by":"publisher","first-page":"20207","DOI":"10.1021\/acs.jmedchem.5c01256","volume":"68","author":"Y He","year":"2025","unstructured":"He Y, Li S, Chen Y, Xu Y, Wang Y, Chen Z, et al. Discovery of Potent and Selective FABP4\/5 Inhibitors with an Isoquinolone Scaffold as Potential Therapeutics for Inflammation-Related Diseases. J Med Chem. 2025;68(19):20207\u201327.","journal-title":"J Med Chem"},{"key":"3728_CR68","doi-asserted-by":"crossref","unstructured":"Xu Z, Zhuang L, Gan B. FABP5 drives ferroptosis in psoriasis. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01629-x"},{"key":"3728_CR69","doi-asserted-by":"crossref","unstructured":"Mieczkowski K, Bakiri L, Martins BS, Matsuoka K, Wagner EF. Fatty acid-binding protein 5 aggravates psoriasis and psoriasis-like disease through ferroptosis. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01630-4"},{"key":"3728_CR70","doi-asserted-by":"publisher","first-page":"1280617","DOI":"10.3389\/fsurg.2024.1280617","volume":"11","author":"SY Hsu","year":"2024","unstructured":"Hsu SY, Rau CS, Tsai CH, Chou SE, Su WT, Hsieh CH. Association of easy albumin-bilirubin score with increased mortality in adult trauma patients. Front Surg. 2024;11:1280617.","journal-title":"Front Surg"},{"key":"3728_CR71","doi-asserted-by":"crossref","unstructured":"Azimjonov J, Ozmen A, Varan M. A vision-based real-time traffic flow monitoring system for road intersections. Multimed Tools Appl. 2023;82:25155\u201374.","DOI":"10.1007\/s11042-023-14418-w"},{"key":"3728_CR72","doi-asserted-by":"publisher","first-page":"0209","DOI":"10.34133\/bmr.0209","volume":"29","author":"Y Lu","year":"2025","unstructured":"Lu Y, Huang Y, Mao C, Shan P, Wu C, Zhu J, et al. Reactive Oxygen Species-Responsive Ferrocene Nanoparticles Delivering Small Interfering RNA Targeting NOP2\/Sun RNA Methyltransferase Family Member 2 for Gastric Cancer Therapy. Biomater Res. 2025;29:0209.","journal-title":"Biomater Res"},{"key":"3728_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yjmcc.2025.09.009","volume":"209","author":"Z Sun","year":"2025","unstructured":"Sun Z, Li N, Huang M, Li Y, Wang C, Qu Z, et al. Myofibroblast specific knockdown of NSUN2 suppresses cardiac fibrosis post-myocardial infarction. J Mol Cell Cardiol. 2025;209:27\u201336.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"3728_CR74","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1182\/bloodadvances.2020002090","volume":"5","author":"AG Davis","year":"2021","unstructured":"Davis AG, Einstein JM, Zheng D, Jayne ND, Fu XD, Tian B, et al. A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation. Blood Adv. 2021;5(5):1310\u201323.","journal-title":"Blood Adv"},{"issue":"2","key":"3728_CR75","first-page":"145","volume":"43","author":"A Yokota","year":"2020","unstructured":"Yokota A, Huo L, Lan F, Wu J, Huang G. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies. Mol Cells. 2020;43(2):145\u201352.","journal-title":"Mol Cells"},{"key":"3728_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-981-10-3233-2_10","volume":"962","author":"WS Liau","year":"2017","unstructured":"Liau WS, Ngoc PC, Sanda T. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis. Adv Exp Med Biol. 2017;962:139\u201347.","journal-title":"Adv Exp Med Biol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03728-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03728-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03728-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:02:59Z","timestamp":1787050979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03728-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3728"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03728-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were approved by the Ethics Committee of Harbin Medical University Cancer Hospital (KY2022-05) and performed in compliance with the Animal Care and Use Committee guidelines and the guidelines for Animal Experimentation issued by the Chinese Association for Laboratory Animal Science. This study was reviewed and ratified by the Ethics Committee of Harbin Medical University Cancer Hospital and complied with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"312"}}